Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of antineoplaston therapy for advanced head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED